409 related articles for article (PubMed ID: 33391509)
21. Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities.
Shi YY; Wei B; Zhou J; Yin ZL; Zhao F; Peng YJ; Yu QW; Wang XL; Chen YJ
Eur J Med Chem; 2022 Dec; 244():114848. PubMed ID: 36274277
[TBL] [Abstract][Full Text] [Related]
22. Endoplasmic Reticulum Stress-Induced NLRP1 Inflammasome Activation Contributes to Myocardial Ischemia/Reperfusion Injury.
Cao L; Chen Y; Zhang Z; Li Y; Zhao P
Shock; 2019 Apr; 51(4):511-518. PubMed ID: 30286036
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA miR-24-3p Reduces Apoptosis and Regulates Keap1-Nrf2 Pathway in Mouse Cardiomyocytes Responding to Ischemia/Reperfusion Injury.
Xiao X; Lu Z; Lin V; May A; Shaw DH; Wang Z; Che B; Tran K; Du H; Shaw PX
Oxid Med Cell Longev; 2018; 2018():7042105. PubMed ID: 30622671
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
Ren X; Yu J; Guo L; Ma H
Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
[TBL] [Abstract][Full Text] [Related]
25. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
26. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
[TBL] [Abstract][Full Text] [Related]
27. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
[TBL] [Abstract][Full Text] [Related]
28. Discovery of cinnamamide-barbiturate hybrids as a novel class of Nrf2 activator against myocardial ischemia/reperfusion injury.
Wei B; Zhang J; Li NN; Yang LH; Xu XL; Shi YY; Liu SH; Chen YJ
Bioorg Chem; 2022 Jul; 124():105828. PubMed ID: 35490584
[TBL] [Abstract][Full Text] [Related]
29. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1.
Suzuki T; Muramatsu A; Saito R; Iso T; Shibata T; Kuwata K; Kawaguchi SI; Iwawaki T; Adachi S; Suda H; Morita M; Uchida K; Baird L; Yamamoto M
Cell Rep; 2019 Jul; 28(3):746-758.e4. PubMed ID: 31315052
[TBL] [Abstract][Full Text] [Related]
31. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
32. Artemisinin suppresses myocardial ischemia-reperfusion injury via NLRP3 inflammasome mechanism.
Wang F; Gao Q; Yang J; Wang C; Cao J; Sun J; Fan Z; Fu L
Mol Cell Biochem; 2020 Nov; 474(1-2):171-180. PubMed ID: 32729005
[TBL] [Abstract][Full Text] [Related]
33. Prospective type 1 and type 2 disulfides of Keap1 protein.
Holland R; Hawkins AE; Eggler AL; Mesecar AD; Fabris D; Fishbein JC
Chem Res Toxicol; 2008 Oct; 21(10):2051-60. PubMed ID: 18729328
[TBL] [Abstract][Full Text] [Related]
34. Aesculin suppresses the NLRP3 inflammasome-mediated pyroptosis via the Akt/GSK3β/NF-κB pathway to mitigate myocardial ischemia/reperfusion injury.
Xu XN; Jiang Y; Yan LY; Yin SY; Wang YH; Wang SB; Fang LH; Du GH
Phytomedicine; 2021 Nov; 92():153687. PubMed ID: 34482222
[TBL] [Abstract][Full Text] [Related]
35. Senescence marker protein 30 confers neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury.
Liu W; Zhao H; Su Y; Wang K; Li J; Xue S; Sun X; Qiu Z
Hum Exp Toxicol; 2021 Mar; 40(3):472-482. PubMed ID: 32909858
[TBL] [Abstract][Full Text] [Related]
36. Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2.
He X; Ma Q
J Pharmacol Exp Ther; 2010 Jan; 332(1):66-75. PubMed ID: 19808700
[TBL] [Abstract][Full Text] [Related]
37. Hace1 overexpression mitigates myocardial hypoxia/reoxygenation injury via the effects on Keap1/Nrf2 pathway.
Chen TY; Zheng SK
In Vitro Cell Dev Biol Anim; 2022 Oct; 58(9):830-839. PubMed ID: 36251153
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA miR-223 modulates NLRP3 and Keap1, mitigating lipopolysaccharide-induced inflammation and oxidative stress in bovine mammary epithelial cells and murine mammary glands.
Zhou M; Barkema HW; Gao J; Yang J; Wang Y; Kastelic JP; Khan S; Liu G; Han B
Vet Res; 2023 Sep; 54(1):78. PubMed ID: 37710276
[TBL] [Abstract][Full Text] [Related]
39. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity.
Yao H; Xie Q; He Q; Zeng L; Long J; Gong Y; Li X; Li X; Liu W; Xu Z; Wu H; Zheng C; Gao Y
Oxid Med Cell Longev; 2022; 2022():9626703. PubMed ID: 35669855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
